{"id":25510,"date":"2025-01-11T12:41:49","date_gmt":"2025-01-11T11:41:49","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&#038;p=25510"},"modified":"2026-04-18T10:15:50","modified_gmt":"2026-04-18T08:15:50","slug":"tirzepatid-20mg","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/cs\/produkt\/tirzepatid-20mg\/","title":{"rendered":"GLP1+GIP 20 mg"},"content":{"rendered":"<div data-elementor-type=\"product-post\" data-elementor-id=\"25510\" class=\"elementor elementor-25510\" data-elementor-post-type=\"product\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0a060c4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0a060c4\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-10a03f2\" data-id=\"10a03f2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8d55ed4 elementor-widget elementor-widget-text-editor\" data-id=\"8d55ed4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2 data-start=\"215\" data-end=\"285\">Tirzepatid 20 mg - molekul\u00e1rn\u00ed charakteristika<\/h2><p data-start=\"287\" data-end=\"654\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Thirzepatide 20mg<\/span><\/span>\u00a0je syntetick\u00fd peptid s molekulovou hmotnost\u00ed p\u0159ibli\u017en\u011b 4813 Da, navr\u017een\u00fd jako du\u00e1ln\u00ed agonista pro receptory GIPR a GLP-1R. Molekula obsahuje modifikovanou sekvenci aminokyselin a lipidov\u00fd \u0159et\u011bzec, kter\u00fd umo\u017e\u0148uje reverzibiln\u00ed vazbu na albumin, co\u017e prodlu\u017euje polo\u010das rozpadu a zvy\u0161uje stabilitu v biologick\u00e9m prost\u0159ed\u00ed.<\/p><p data-start=\"656\" data-end=\"924\">Podle farmakologick\u00fdch anal\u00fdz popsan\u00fdch v p\u0159ehledu Min et al. (2023) vykazuje tirzepatide schopnost aktivovat inkretinov\u00e9 receptory mechanismem z\u00e1visl\u00fdm na Gs proteinech, co\u017e vede ke zv\u00fd\u0161en\u00ed hladiny cAMP a aktivaci n\u00e1sledn\u00fdch signaliza\u010dn\u00edch kask\u00e1d.<\/p><hr data-start=\"926\" data-end=\"929\" \/><h2 data-start=\"931\" data-end=\"1000\">Receptorov\u00fd mechanismus thiothrombidu 20 mg - \u00fadaje z preklinick\u00fdch a klinick\u00fdch studi\u00ed<\/h2><p data-start=\"1002\" data-end=\"1047\">Du\u00e1ln\u00ed aktivace GIPR a GLP-1R vede k:<\/p><ul data-start=\"1049\" data-end=\"1253\"><li data-start=\"1049\" data-end=\"1095\"><p data-start=\"1051\" data-end=\"1095\">zv\u00fd\u0161en\u00ed sekrece inzul\u00ednu z\u00e1visl\u00e9 na gluk\u00f3ze,<\/p><\/li><li data-start=\"1096\" data-end=\"1160\"><p data-start=\"1098\" data-end=\"1160\">inhibice sekrece glukagonu za hyperglykemick\u00fdch podm\u00ednek,<\/p><\/li><li data-start=\"1161\" data-end=\"1198\"><p data-start=\"1163\" data-end=\"1198\">zpomalen\u00ed vyprazd\u0148ov\u00e1n\u00ed \u017ealudku,<\/p><\/li><li data-start=\"1199\" data-end=\"1253\"><p data-start=\"1201\" data-end=\"1253\">\u00fa\u010dinky na centr\u00e1ln\u00ed mechanismy reguluj\u00edc\u00ed chu\u0165 k j\u00eddlu.<\/p><\/li><\/ul><p data-start=\"1255\" data-end=\"1410\">Studie in vitro uk\u00e1zaly, \u017ee aktivace t\u011bchto receptor\u016f zvy\u0161uje hladinu cAMP a moduluje expresi gen\u016f souvisej\u00edc\u00edch s metabolismem gluk\u00f3zy a lipid\u016f.<\/p><p data-start=\"1412\" data-end=\"1607\">Mechanistick\u00fd p\u0159ehled (Min T. et al., 2023) zd\u016fraz\u0148uje, \u017ee sou\u010dasn\u00e1 aktivace GIP a GLP-1 m\u016f\u017ee v\u00e9st k synergick\u00fdm \u00fa\u010dink\u016fm p\u0159esahuj\u00edc\u00edm sou\u010det \u00fa\u010dink\u016f jednotliv\u00fdch agonist\u016f.<\/p><p data-start=\"1609\" data-end=\"1669\">Zdroj:<br data-start=\"1616\" data-end=\"1619\" \/><a class=\"decorated-link\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10107501\/\" target=\"_new\" rel=\"noopener\" data-start=\"1619\" data-end=\"1669\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10107501\/<\/a><\/p><hr data-start=\"1671\" data-end=\"1674\" \/><h2 data-start=\"1676\" data-end=\"1744\">Klinick\u00e9 n\u00e1lezy - anal\u00fdza nejvy\u0161\u0161\u00edch \u00farovn\u00ed expozice<\/h2><p data-start=\"1746\" data-end=\"1897\">Ve studii SURMOUNT-1 publikovan\u00e9 v \u010dasopise <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">New England Journal of Medicine<\/span><\/span> (2022) hodnotili vliv tirzepatydu na t\u011blesnou hmotnost po 72 t\u00fddnech sledov\u00e1n\u00ed.<\/p><p data-start=\"1899\" data-end=\"1963\">U nejvy\u0161\u0161\u00ed d\u00e1vky analyzovan\u00e9 ve studii (15 mg) bylo uvedeno:<\/p><ul data-start=\"1965\" data-end=\"2127\"><li data-start=\"1965\" data-end=\"2003\"><p data-start=\"1967\" data-end=\"2003\">pr\u016fm\u011brn\u00e9 sn\u00ed\u017een\u00ed hmotnosti o 20,9%,<\/p><\/li><li data-start=\"2004\" data-end=\"2057\"><p data-start=\"2006\" data-end=\"2057\">\u226520% sn\u00ed\u017een\u00ed hmotnosti u v\u00edce ne\u017e 50% \u00fa\u010dastn\u00edk\u016f,<\/p><\/li><li data-start=\"2058\" data-end=\"2127\"><p data-start=\"2060\" data-end=\"2127\">zlep\u0161en\u00ed lipidov\u00fdch parametr\u016f a sn\u00ed\u017een\u00ed systolick\u00e9ho krevn\u00edho tlaku.<\/p><\/li><\/ul><p data-start=\"2129\" data-end=\"2306\">Ve studii SURPASS-2 (NEJM 2021) bylo prok\u00e1z\u00e1no, \u017ee tirzepatide vedl k v\u011bt\u0161\u00edmu sn\u00ed\u017een\u00ed HbA1c ne\u017e tirzepatide. <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Semaglutid<\/span><\/span> a k v\u00fdrazn\u00e9mu sn\u00ed\u017een\u00ed t\u011blesn\u00e9 hmotnosti.<\/p><p data-start=\"2308\" data-end=\"2403\">Zdroje:<br data-start=\"2315\" data-end=\"2318\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\" target=\"_new\" rel=\"noopener\" data-start=\"2318\" data-end=\"2359\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/<\/a><br data-start=\"2359\" data-end=\"2362\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34170647\/\" target=\"_new\" rel=\"noopener\" data-start=\"2362\" data-end=\"2403\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34170647\/<\/a><\/p><p data-start=\"2405\" data-end=\"2495\">Tyto \u00fadaje ukazuj\u00ed na jasnou z\u00e1vislost \u00fa\u010dinku na d\u00e1vce a intenzit\u011b aktivace receptor\u016f.<\/p><hr data-start=\"2497\" data-end=\"2500\" \/><h2 data-start=\"2502\" data-end=\"2537\">V\u00fdzkumn\u00fd v\u00fdznam varianty tirzepatid 20mg<\/h2><p data-start=\"2539\" data-end=\"2676\">A\u010dkoli v registra\u010dn\u00edch studi\u00edch byly analyzov\u00e1ny d\u00e1vky a\u017e do 15 mg, 20 mg varianta poskytuje model v laboratorn\u00edm prost\u0159ed\u00ed pro hodnocen\u00ed:<\/p><ul data-start=\"2678\" data-end=\"2861\"><li data-start=\"2678\" data-end=\"2729\"><p data-start=\"2680\" data-end=\"2729\">maxim\u00e1ln\u00ed aktivace inkretinov\u00fdch receptor\u016f,<\/p><\/li><li data-start=\"2730\" data-end=\"2761\"><p data-start=\"2732\" data-end=\"2761\">vztah mezi d\u00e1vkou a odezvou,<\/p><\/li><li data-start=\"2762\" data-end=\"2798\"><p data-start=\"2764\" data-end=\"2798\">Intenzita signalizace GPCR,<\/p><\/li><li data-start=\"2799\" data-end=\"2861\"><p data-start=\"2801\" data-end=\"2861\">metabolick\u00e9 \u00fa\u010dinky p\u0159i vy\u0161\u0161\u00ed expozici receptor\u016f.<\/p><\/li><\/ul><p data-start=\"2863\" data-end=\"3023\">Na zv\u00ed\u0159ec\u00edch modelech vedla aktivace osy GIP\/GLP-1 ke zm\u011bn\u00e1m exprese gen\u016f souvisej\u00edc\u00edch s metabolismem lipid\u016f a regulac\u00ed metabolismu sacharid\u016f.<\/p><hr data-start=\"3025\" data-end=\"3028\" \/><h2 data-start=\"3030\" data-end=\"3060\">Povaha a kvalita materi\u00e1lu<\/h2><p data-start=\"3062\" data-end=\"3192\">Tirzepatid 20 mg nab\u00edzen\u00fd jako testovan\u00fd materi\u00e1l p\u0159edstavuje referen\u010dn\u00ed l\u00e1tku pro biochemick\u00e9 a farmakologick\u00e9 anal\u00fdzy.<\/p><p data-start=\"3194\" data-end=\"3357\">Kvalita produktu by m\u011bla b\u00fdt potvrzena analytickou dokumentac\u00ed (nap\u0159. HPLC profil, certifik\u00e1t anal\u00fdzy - CoA), kter\u00e1 zajist\u00ed reprodukovatelnost experiment\u00e1ln\u00edch v\u00fdsledk\u016f.<\/p><p data-start=\"3359\" data-end=\"3451\">Produkt je ur\u010den pouze pro v\u00fdzkumn\u00e9 a analytick\u00e9 pou\u017eit\u00ed (Research Use Only).<\/p><hr data-start=\"3025\" data-end=\"3028\" \/><h2 data-start=\"127\" data-end=\"195\">Thirzepatid vs Semaglutid vs Retatrutid - mechanismus receptoru<\/h2><p data-start=\"197\" data-end=\"450\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Semaglutid<\/span><\/span>, <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Tirzepatid<\/span><\/span> a <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Retatrutid<\/span><\/span> pat\u0159\u00ed do skupiny pokro\u010dil\u00fdch inkretinov\u00fdch agonist\u016f, kter\u00e9 se li\u0161\u00ed m\u00edrou aktivace receptor\u016f a farmakodynamick\u00fdm profilem.<\/p><p data-start=\"452\" data-end=\"661\"><strong data-start=\"452\" data-end=\"467\">Semaglutid<\/strong> p\u016fsob\u00ed selektivn\u011b na receptor GLP-1R. Aktivace tohoto receptoru vede ke zv\u00fd\u0161en\u00ed hladin cAMP, modulaci inzulinotropn\u00ed odpov\u011bdi a ovlivn\u011bn\u00ed centr\u00e1ln\u00edch mechanism\u016f reguluj\u00edc\u00edch chu\u0165 k j\u00eddlu.<\/p><p data-start=\"663\" data-end=\"1138\"><strong data-start=\"663\" data-end=\"678\">Tirzepatid<\/strong>, v\u010detn\u011b mo\u017enosti ozna\u010dovan\u00e9 jako <strong data-start=\"709\" data-end=\"728\">tirzepatid 20mg<\/strong>, vykazuje du\u00e1ln\u00ed mechanismus \u00fa\u010dinku prost\u0159ednictv\u00edm sou\u010dasn\u00e9 aktivace receptor\u016f GLP-1R a GIPR. Integrace t\u011bchto dvou inkretinov\u00fdch os vede ke zv\u00fd\u0161en\u00e9 cAMP-dependentn\u00ed odpov\u011bdi a v\u00fdrazn\u00e9mu \u00fa\u010dinku z\u00e1visl\u00e9mu na d\u00e1vce pozorovan\u00e9mu v klinick\u00fdch studi\u00edch. Literatura uv\u00e1d\u00ed, \u017ee du\u00e1ln\u00ed agonismus GIP + GLP-1 m\u016f\u017ee vyvolat synergick\u00fd \u00fa\u010dinek p\u0159esahuj\u00edc\u00ed \u00fa\u010dinek selektivn\u00edho agonisty GLP-1.<\/p><p data-start=\"1140\" data-end=\"1400\"><strong data-start=\"1140\" data-end=\"1155\">Retatrutid<\/strong> p\u0159edstavuje slo\u017eit\u011bj\u0161\u00ed model - aktivuje GLP-1R, GIPR a glukagonov\u00fd receptor (GCGR). Takov\u00fd triagonismus roz\u0161i\u0159uje metabolickou odpov\u011b\u010f o dal\u0161\u00ed mechanismy souvisej\u00edc\u00ed s regulac\u00ed metabolismu lipid\u016f a energetick\u00fdch substr\u00e1t\u016f.<\/p><p data-start=\"1402\" data-end=\"1431\">Shr\u0148me mechanicky:<\/p><ul data-start=\"1433\" data-end=\"1596\"><li data-start=\"1433\" data-end=\"1478\"><p data-start=\"1435\" data-end=\"1478\">semaglutid, selektivn\u00ed agonista GLP-1R,<\/p><\/li><li data-start=\"1479\" data-end=\"1547\"><p data-start=\"1481\" data-end=\"1547\">tirzepatide \/ tirzepatid 20 mg - du\u00e1ln\u00ed agonista GLP-1R a GIPR,<\/p><\/li><li data-start=\"1548\" data-end=\"1596\"><p data-start=\"1550\" data-end=\"1596\">retatrutid - triagonista GLP-1R, GIPR a GCGR.<\/p><\/li><\/ul><p data-start=\"1598\" data-end=\"1710\">Rozsah aktivovan\u00fdch receptor\u016f je kl\u00ed\u010dov\u00fdm prvkem pro rozli\u0161en\u00ed t\u011bchto molekul ve farmakologick\u00fdch studi\u00edch.<\/p><hr data-start=\"1712\" data-end=\"1715\" \/><h2 data-start=\"1717\" data-end=\"1783\">Thirzepatide 20mg - dostupnost a kde koupit (research nature)<\/h2><p data-start=\"1785\" data-end=\"1942\">V laboratorn\u00edm kontextu <strong data-start=\"1813\" data-end=\"1832\">tirzepatid 20mg<\/strong> slou\u017e\u00ed jako referen\u010dn\u00ed materi\u00e1l pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely (Research Use Only).<\/p><p data-start=\"1944\" data-end=\"2071\">L\u00e1tky tohoto typu nab\u00edzej\u00ed specializovan\u00ed dodavatel\u00e9 \u010dinidel a analytick\u00fdch materi\u00e1l\u016f, kte\u0159\u00ed poskytuj\u00ed:<\/p><ul data-start=\"2073\" data-end=\"2226\"><li data-start=\"2073\" data-end=\"2128\"><p data-start=\"2075\" data-end=\"2128\">dokumentaci kvality (certifik\u00e1t o anal\u00fdze - CoA),<\/p><\/li><li data-start=\"2129\" data-end=\"2174\"><p data-start=\"2131\" data-end=\"2174\">potvrzen\u00fd profil \u010distoty (nap\u0159. HPLC),<\/p><\/li><li data-start=\"2175\" data-end=\"2226\"><p data-start=\"2177\" data-end=\"2226\">identifikace \u0161ar\u017ee a podm\u00ednky skladov\u00e1n\u00ed.<\/p><\/li><\/ul><p data-start=\"2228\" data-end=\"2344\">Na v\u00fdzkumn\u00e9m trhu je d\u016fle\u017eit\u00e9 potvrdit analytickou kvalitu a kompatibilitu s \u00fa\u010delem experimentu.<\/p><p data-start=\"2346\" data-end=\"2464\">P\u0159\u00edpravek nen\u00ed ur\u010den k samostatn\u00e9mu terapeutick\u00e9mu pou\u017eit\u00ed nebo k pou\u017eit\u00ed mimo kontrolovan\u00e9 studie.<\/p><p data-start=\"2346\" data-end=\"2464\"><a href=\"https:\/\/tirzepatyd.eu\/de\/shop-produkt\/tirzepatide-20-mg-stift\">Viz tak\u00e9 Tirzepatide 20 mg v za\u0159\u00edzen\u00ed (pero)<\/a><\/p><hr data-start=\"1712\" data-end=\"1715\" \/><p data-start=\"2346\" data-end=\"2464\"><a href=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-35032 size-medium aligncenter\" src=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg-300x225.png\" alt=\"Tirzepatid 20mg in vial \u2013 high purity laboratory peptide\" width=\"300\" height=\"225\" srcset=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg-300x225.png 300w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg-768x576.png 768w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg-16x12.png 16w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg-800x600.png 800w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg-400x300.png 400w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg-64x48.png 64w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2026\/02\/Tirzepatid-20mg.png 1024w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p><hr data-start=\"1712\" data-end=\"1715\" \/><p data-start=\"2346\" data-end=\"2464\"><strong>V\u00fdrobek je ur\u010den pro v\u011bdeck\u00fd v\u00fdzkum a laboratorn\u00ed anal\u00fdzy. V\u0161echny \u010dl\u00e1nky a informace na t\u011bchto webov\u00fdch str\u00e1nk\u00e1ch slou\u017e\u00ed pouze k informa\u010dn\u00edm a vzd\u011bl\u00e1vac\u00edm \u00fa\u010del\u016fm.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p data-start=\"115\" data-end=\"438\"><strong data-start=\"115\" data-end=\"134\">Thirzepatide 20 mg injek\u010dn\u00ed lahvi\u010dka<\/strong> je pokro\u010dil\u00fd syntetick\u00fd peptid s du\u00e1ln\u00ed aktivitou v\u016f\u010di receptor\u016fm GIP a GLP-1, kter\u00fd se pou\u017e\u00edv\u00e1 ve specializovan\u00fdch studi\u00edch inkretinov\u00e9ho metabolismu a signalizace. Varianta 20 mg umo\u017e\u0148uje anal\u00fdzu intenzivn\u00ed aktivace receptor\u016f a vztah\u016f mezi d\u00e1vkou a \u00fa\u010dinkem v laboratorn\u00edch podm\u00ednk\u00e1ch.<\/p>","protected":false},"featured_media":25514,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[124,111,15],"product_tag":[136],"class_list":{"0":"post-25510","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-fiolce","7":"product_cat-glp1gip","8":"product_cat-laboratory-research","9":"product_tag-fiolka","11":"first","12":"instock","13":"shipping-taxable","14":"purchasable","15":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/25510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/comments?post=25510"}],"version-history":[{"count":15,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/25510\/revisions"}],"predecessor-version":[{"id":35456,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/25510\/revisions\/35456"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media\/25514"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media?parent=25510"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_brand?post=25510"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_cat?post=25510"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_tag?post=25510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}